AstraZeneca Can't Prevent FDA Approval Of Generic Seroquel

Law360, New York (March 23, 2012, 8:20 PM EDT) -- A Washington federal judge on Friday tossed AstraZeneca PLC's suit seeking to delay the launch of generic versions of its blockbuster anti-psychotic drug Seroquel with labels that omit hyperglycemia warnings AstraZeneca was required to add, finding the drugmaker's claim was not yet ripe for review.

U.S. District Judge Colleen Kollar-Kotelly also denied AstraZeneca's bid for a preliminary injunction to stop the U.S. Food and Drug Administration from giving final approval to a generic version of Seroquel, finding the company had failed to show it was entitled...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ADMINISTRATION et al


Case Number

1:12-cv-00388

Court

District Of Columbia

Nature of Suit

Other Statutory Actions

Judge

Colleen Kollar-Kotelly

Date Filed

March 12, 2012

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.